AMGT 0230
Alternative Names: AMGT-0230Latest Information Update: 04 Jun 2025
At a glance
- Originator Amalgent Therapeutics
- Class Analgesics; Antidepressants; Antiparkinsonians; Benzothiazoles; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists; Dopamine D3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Pain
Most Recent Events
- 30 May 2025 Early research in Pain in USA (PO) (Amalgent Therapeutics pipeline; May 2025)